Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) — Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the upcoming H.C. Wainwright Global Life Sciences Conference.